Needle-free Injection Device is a type of medical injecting syringe that uses a high-pressure narrow jet of the injection liquid instead of a hypodermic needle to penetrate the epidermis. It is powered by compressed air or gas, either by a pressure hose from a large cylinder, or form a built-in gas cartridge, small cylinder, or spring.
Needle-free injection systems are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. It was developed to reduce the number of needle stick accidents and associated problems.
Scope of the Report:This report focuses on the Needle-Free Injection Device in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Firstly, the technology of needle-free injection device industry is developing and the industry concentration is not high, There are over 30 manufacturers around the world, and the leading companies are Zogenix, Bioject, Glide Pharma, Crossject Medical and Injex Pharma, right now the production is almost dominated by producers in Europe and United States. In United States, a few companies occupy more than 60 percent of domestic needle-free injector market. On the other hand, almost all the high-end products produced by the global leaders, and the producers mainly produce low-end products in China and India. USA and Europe have a long history and unshakable status in this industry, such as Bioject and Akra Dermojet, leading the needle-free injection device industry. As to Japan, many big corporation has come into this area, however, the rate of the business in this area is not high compared to other area because Japanese companies always have many business areas. In Germany, it is Injex Pharma that lead the industry.
Nonetheless, this market is not big because the relatively high price of the needle-free injectors compared to the disposable injectors. Mergers and acquisitions usually happen amony needle-free injection devices producers. For example, Bioject has been purchased by Inovio.
Globally, the global production was 2927 K units in 2015, and it will reach 4587K units in 2021. The global production value was 299.39 million USD in 2015, and it is expected that the value will be 436.3 million USD in 2021, with9.14% annual compound growth.
The worldwide market for Needle-Free Injection Device is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2026, from xx million US$ in 2020, according to a new study.
Market Segment by Manufacturers, this report covers Zogenix
Inovio
Glide Pharma
Akra Dermojet
Crossject Medical Technology
Injex Pharma
Eternity Healthcare
Antares Pharma
Valeritas
Medical International Technologies
Penjet
PharmaJet
National Medical Products
Activa Brand Products
Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers Powder Injections
Liquid Injections
Depot or Projectile Injection
Market Segment by Applications, can be divided into Drug Injection
Cosmetic Surgery Use
Other
There are 15 Chapters to deeply display the global Needle-Free Injection Device market.
Chapter 1, to describe Needle-Free Injection Device Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Needle-Free Injection Device, with sales, revenue, and price of Needle-Free Injection Device, in 2018 and 2019;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2018 and 2019;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Needle-Free Injection Device, for each region, from 2015 to 2020;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2015 to 2020;
Chapter 12, Needle-Free Injection Device market forecast, by regions, type and application, with sales and revenue, from 2020 to 2026;
Chapter 13, 14 and 15, to describe Needle-Free Injection Device sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
